Photoacoustic imaging gives researchers an inside look at arterial plaque

An international team of researchers from Purdue University in Indiana and the Shanghai Institute of Optics and Fine Mechanics in Shanghai, China, have developed a highly sensitive imaging probe capable of more accurately assessing impending risks to patients resulting from arterial plaques.

Known as intravascular photoacoustic imaging (IVPA), the innovative tool produces 3D images of arteries from the inside out, allowing doctors to diagnose plaques on the brink of rupturing, said lead author and postdoctoral researcher Yingchun Cao.

"The most exciting part of this work … is the collinear design of the catheter that enables the intravascular photoacoustic imaging system to see much deeper and much more lipid information in the arteries," he said in a university press release. "That could provide valuable help for the doctor to better identify and diagnose the plaque vulnerability in patients."

Arterial plague accumulation, also known as atherosclerosis, is a common form of cardiovascular disease, which remains the world’s leading cause of death.

The newly designed probe improves on previous instruments in terms of plague assessment by giving doctors a way to accurately diagnose rupture risks in living patients.

Read more about the scientists’ research.

 

 

John Hocter,

Digital Editor

With nearly a decade of experience in print and digital publishing, John serves as Content Marketing Manager. His professional skill set includes feature writing, content marketing and social media strategy. A graduate of The Ohio State University, John enjoys spending time with his wife and daughter, along with a number of surprisingly mischievous indoor cacti.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.